Literature DB >> 19921975

Association between the ionotropic glutamate receptor kainate3 (GRIK3) Ser310Ala polymorphism and schizophrenia in the Indian population.

Yusra Ahmad1, Manjeet S Bhatia, Pramod K Mediratta, Krishna K Sharma, Harsh Negi, Kunzang Chosdol, Subrata Sinha.   

Abstract

Various studies have been done to check the status of glutamate receptor gene in the pathogenesis of schizophrenia. The T928G (Ser310Ala) polymorphism of ionotropic glutamate receptor kainate 3 gene (GRIK3) and its positive association with schizophrenia was reported in Caucasians, whereas no association of this polymorphism with schizophrenia was shown in two other populations, Chinese and Japanese. However, no literature is available regarding the prevalence of this polymorphism and its association with schizophrenia in the Indian population. As genetic susceptibility profiles in India are often different from those of white Caucasians or Orientals, we investigated the status of Ser310Ala polymorphism of GRIK3 in 100 schizophrenic patients and 100 healthy controls in the Indian population by the PCR-RFLP (restriction fragment length polymorphism) method. A statistically significant difference in the genotype and allelic distributions (P<0.000001 and P=0.01, respectively) of Ser310Ala polymorphism was found in schizophrenics than in control, considering Ala-allele as being associated with the disease (OR=1.7, 95% CI=1.137-2.540). Our study suggests a potential role for GRIK3 for susceptibility to schizophrenia in Indian population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921975     DOI: 10.3109/15622970802688044

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  8 in total

Review 1.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

2.  A Neural "Tuning Curve" for Multisensory Experience and Cognitive-Perceptual Schizotypy.

Authors:  Francesca Ferri; Yuliya S Nikolova; Mauro Gianni Perrucci; Marcello Costantini; Antonio Ferretti; Valentina Gatta; Zirui Huang; Richard A E Edden; Qiang Yue; Marco D'Aurora; Etienne Sibille; Liborio Stuppia; Gian Luca Romani; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 3.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

4.  Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Beverly H Koller; Sheryl S Moy
Journal:  Brain Res       Date:  2012-01-20       Impact factor: 3.252

Review 5.  The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.

Authors:  Ke Wu; Gregory L Hanna; David R Rosenberg; Paul D Arnold
Journal:  Pharmacol Biochem Behav       Date:  2011-10-15       Impact factor: 3.533

Review 6.  Structure, Function, and Regulation of the Kainate Receptor.

Authors:  Surbhi Dhingra; Juhi Yadav; Janesh Kumar
Journal:  Subcell Biochem       Date:  2022

7.  Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Authors:  Dongjun Dai; Yunliang Wang; Jiaojiao Yuan; Xingyu Zhou; Danjie Jiang; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-06-30

8.  Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.

Authors:  Paulina Chałupnik; Alina Vialko; Darryl S Pickering; Markus Hinkkanen; Stephanie Donbosco; Thor C Møller; Anders A Jensen; Birgitte Nielsen; Yasmin Bay; Anders S Kristensen; Tommy N Johansen; Kamil Łątka; Marek Bajda; Ewa Szymańska
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.